← back to search

Jayakumar R. Nair

Roswell Park Comprehensive Cancer Center · US
Area of research
Hematology · Oncology
Research interest
Research interests include CD28, Durvalumab, PARP inhibitor, Olaparib, Ovarian cancer, and Medicine.
h-index
citations
370
works
3
NIH funding
primary concept
email

Recent publications

Combination of PARP Inhibitor Olaparib, and PD-L1 Inhibitor Durvalumab, in Recurrent Ovarian Cancer: a Proof-of-Concept Phase II Study
Clinical Cancer Research 2020cited by 221position: middledoi
CD28 Promotes Plasma Cell Survival, Sustained Antibody Responses, and BLIMP-1 Upregulation through Its Distal PYAP Proline Motif
The Journal of Immunology 2015cited by 58position: middledoi
CD28-mediated pro-survival signaling induces chemotherapeutic resistance in multiple myeloma
Blood 2014cited by 91position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Adam Utley · Roswell Park Comprehensive Cancer Center2 papers (2014–2015)Louise Carlson · Roswell Park Comprehensive Cancer Center2 papers (2014–2015)Kelvin P. Lee · Indiana University Health2 papers (2014–2015)Lawrence Boise · Emory University2 papers (2014–2015)Megan Murray · Roswell Park Comprehensive Cancer Center2 papers (2014–2015)Ashley Cimino‐Mathews · Bloomberg (United States)1 papers (2020–2020)Stanley Lipkowitz · Center for Cancer Research1 papers (2020–2020)Marc R. Radke · University of Washington1 papers (2020–2020)Alexandra S. Zimmer · Center for Cancer Research1 papers (2020–2020)Zhengyu Yang · Monash University1 papers (2015–2015) · 1 papers (2015–2015) · 1 papers (2015–2015)Elizabeth M. Swisher · University of Washington1 papers (2020–2020)Chandana Koorella · Roswell Park Comprehensive Cancer Center1 papers (2014–2014)Jung‐Min Lee · University of California System1 papers (2020–2020) · 1 papers (2020–2020)James W. Hodge · National Institutes of Health1 papers (2020–2020)Erika J. Lampert · The Ohio State University Wexner Medical Center1 papers (2020–2020)P. Leif Bergsagel · Mayo Clinic in Arizona1 papers (2014–2014)Marta Chesi · Arizona State University1 papers (2014–2014)